PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Study sponsor: VistaGen Therapeutics, Inc. · VTGN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-06-22Actual
Enrollment · participants224Actual
Source updated2025-09-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.